COMPTOLIFE
                                                        By                              
        
      
BABRIC
LifeScienceInnovations

 WHO WE ARE

          BABRICLifeScienceInnovations
is a start-up Medical Device Company focused on creating advanced Life Science and Healthcare Technologies.

          
COMPTO
LIFE is a start-up Medical Device Company evolved from
BABRICLifeScienceInnovations
with a concentration on developing its numerous Intellectual Properties for the treatment of Sudden Cardiac Arrest (SCA) -- specifically with  Universal Defibrillator Access:
 

      »  Ada
ptation of common tablet and laptop computers through the direct embedding of AED and/or manual defibrillator capabilities at the time of manufacture; to enable each to be used as an automated external defibrillator (AED) and/or a manual defibrillator, to treat victims of Sudden Cardiac Arrest (SCA).
     
     

     
»  Various Kits and Methods for retrofitting and adapting aftermarket tablet
and laptop computers to enable each to be used as an automated external defibrillator (AED), and/or as a  manual defibrillator.
     
A recent Report by the IOM (Institute of Medicine) “Strategies To Improve Cardiac Arrest Survival -- A Time to Act” (June 30, 2015)  states that every year in the U.S. about 395,000 cases of cardiac arrest occur outside hospitals, and less than 6 percent of these victims survive.  These statistics validate and reinforce the need for additional technologies to expand the status quo.

Key in the process of resuscitation is the immediate initiation of quality cardiopulmonary resuscitation (CPR), and the early use of automated external defibrillators (AEDs) by bystanders pending arrival of professional rescuers.

According to the American Heart Association, early CPR and rapid defibrillation combined with early advanced care can produce high long-term survival rates.  When bystanders provide immediate CPR, and the first shock is delivered within 3 to 5 minutes, the reported survival rates from sudden cardiac arrest are as high as 48 to 74 percent.

By providing quick and easy access to reliable computer/AEDs, COMPTOLIFE'S
technologies have the prospects for supplying a critically needed addition and complement to the "current state of the art", which is Public Access Defibrillation (PAD), or automated external defibrillators (AEDs) placed in airports and other transportation centers, schools, large shopping malls, sports complexes, large industrial sites, and other public places. COMPTOLIFE Devices will serve to increase the overall availability and ready access to vitally needed defibrillators by both medical professionals and the general public.

Through universal access to reliable Computer/AED Devices and widespread training of the public, COMPTOLIFE has the potential for markedly impacting current statistics.

To start, the Company sees ideal "fits" for its technologies with rugged laptops and tablets used in the field; such as by first responders, the military, and in government, sports, and industry.  And, utilizing its manual defibrillator option, with mobile clinical assistants (MCAs); rapidly increasing in use by physicians, nurses, and other medical support staff, with the current trend toward electronic health records (EHRs).

COMPTOLIFE is currently moving forward with the development of its innovative technologies through the design, engineering and prototyping of several of its numerous Devices.
                                                           ________________________

TONABA HealthScience, a Subsidiary of BABRICLifeScienceInnovations, has innovative technologies for detecting the silent rupture of breast implants and other prostheses.

 



Website Builder